Raj Chovatiya, MD, PhD: Safety of Oral JAK Inhibitors for Atopic Dermatitis

Dr. Chovatiya discusses safety data on upadacitinib and abrocitinib for the treatment of atopic dermatitis.

MORE CONFERENCE COVERAGE

Dr. Harper recaps her session from Maui Derm NP+PA Fall, in which she discussed moving away from rosacea subtypes as well as new insights in rosacea pathogenesis and treatment. ...